Literature DB >> 15284201

Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.

Takeshi Nagamatsu1, Tomoyuki Fujii, Maki Kusumi, Li Zou, Takahiro Yamashita, Yutaka Osuga, Mikio Momoeda, Shirou Kozuma, Yuji Taketani.   

Abstract

Sufficient cytotrophoblast (CT) invasion into the uterine wall and subsequent remodeling of maternal uterine vasculature is critical to establish uteroplacental circulation. The production of vascular endothelial growth factor (VEGF) family molecules is confirmed in placental cells including CTs, but it is not elucidated how the VEGF system in CTs is controlled by oxygen tension and how it is involved in the development of placental circulation. To address this, we explored the effect of oxygen tension on the expression of VEGF, placenta growth factor (PlGF), and their antagonist, soluble fms-like tyrosine kinase-1 (sFlt-1) using ELISA and real-time PCR in a primary CT cell culture. For comparison, the same was conducted in parallel using other cells comprising placenta, such as human umbilical vein endothelial cells (HUVECs) and villous fibroblasts (VFs). Reduced oxygen resulted in a pronounced increase in sFlt-1 mRNA amount and sFlt-1 release into the culture media in CTs, whereas this was not the case with HUVECs and VFs. Free (not bound to sFlt-1) VEGF was not detected in CT culture media regardless of oxygen concentration, even though VEGF expression was stimulated by reduced oxygen in CTs, which was similar to the stimulation in HUVECs and VFs. Free PlGF was also diminished in CT culture media by reduced oxygen. These results implicate that CTs possess a unique property to enhance sFlt-1 production under reduced oxygen, which could consequently antagonize angiogenic activity of VEGF and PlGF. The presented findings might provide a framework with which to understand the mechanism of uterine vascular remodeling and its perturbations as exemplified in preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284201     DOI: 10.1210/en.2004-0533

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  92 in total

1.  L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats.

Authors:  Sydney R Murphy; Babbette LaMarca; Kathy Cockrell; Marietta Arany; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

2.  Recent insights into the pathophysiology of preeclampsia.

Authors:  Eric M George; Joey P Granger
Journal:  Expert Rev Obstet Gynecol       Date:  2010-09-01

3.  Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia.

Authors:  S Guller; Z Tang; Y Y Ma; S Di Santo; R Sager; H Schneider
Journal:  Placenta       Date:  2010-11-11       Impact factor: 3.481

4.  A role of the anti-angiogenic factor sVEGFR-1 in the 'mirror syndrome' (Ballantyne's syndrome).

Authors:  Jimmy Espinoza; Roberto Romero; Jyh Kae Nien; Juan Pedro Kusanovic; Karina Richani; Ricardo Gomez; Chong Jai Kim; Pooja Mittal; Francesca Gotsh; Offer Erez; Tinnakorn Chaiworapongsa; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2006-10

5.  Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.

Authors:  Ori Nevo; Nima Soleymanlou; Yuan Wu; Jing Xu; John Kingdom; Ariel Many; Stacy Zamudio; Isabella Caniggia
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-04-20       Impact factor: 3.619

Review 6.  Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia.

Authors:  Yang Xia; Susan M Ramin; Rodney E Kellems
Journal:  Hypertension       Date:  2007-06-18       Impact factor: 10.190

7.  IL-24 expression at maternal-fetal interface and its roles in trophoblast invasion.

Authors:  Hong Cheng; Li Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-08-15

8.  Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia.

Authors:  Seth Guller; Catalin S Buhimschi; Yula Y Ma; Se Te J Huang; Liubin Yang; Edward Kuczynski; Eduardo Zambrano; Charles J Lockwood; Irina A Buhimschi
Journal:  Lab Invest       Date:  2008-08-04       Impact factor: 5.662

Review 9.  The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.

Authors:  Frederick Schatz; Ozlem Guzeloglu-Kayisli; Sefa Arlier; Umit A Kayisli; Charles J Lockwood
Journal:  Hum Reprod Update       Date:  2016-02-23       Impact factor: 15.610

10.  Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Zeynep Alpay Savasan; Juan Pedro Kusanovic; Giovanna Ogge; Eleazar Soto; Zhong Dong; Adi Tarca; Bhatti Gaurav; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.